Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.15 License Agreement
- 10.16 Form of Neubase Therapeutics, Inc. Warrant Certificate
- 10.17 Form of Neubase Therapeutics, Inc. Note Purchase Agreement
- 10.18 Form of Neubase Therapeutics, Inc. Convertible Promissory Note
- 10.19 Neubase Therapeutics, Inc. 2018 Equity Incentive Plan
- 10.20 Form of Option Agreement
- 10.21 Restricted Stock Purchase Agreement
- 10.22 Amendment to Restricted Stock Purchase Agreement
- 21.1 Subsidiaries of Ohr Pharmaceutical, Inc.
- 23.1 Consent of Malonebailey, LLP Independent Registered Accounting Firm to Ohr
- 23.2 Consent of Malonebailey, LLP, Independent Registered Public Accounting Firm to
- 99.5 Consent of Roth Capital Partners, LLC
- 99.4 Consent of DR. Dietrich Stephan
- Download Excel data file
- View Excel data file
NBSE similar filings
- 22 May 19 Registration of securities issued in business combination transactions (amended)
- 7 May 19 Registration of securities issued in business combination transactions (amended)
- 16 Apr 19 Registration of securities issued in business combination transactions (amended)
- 8 Mar 19 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-4 of our report dated January 3, 2019, except for Note 1 as to which the date is March 7, 2019, with respect to the audited consolidated financial statements of OHR Pharmaceutical, Inc. for the years ended September 30, 2018 and 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
March 7, 2019